These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23844225)

  • 1. Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer.
    Lin WY; Brock IW; Connley D; Cramp H; Tucker R; Slate J; Reed MW; Balasubramanian SP; Cannon-Albright LA; Camp NJ; Cox A
    PLoS One; 2013; 8(7):e68578. PubMed ID: 23844225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.
    Abdel-Fatah TM; Middleton FK; Arora A; Agarwal D; Chen T; Moseley PM; Perry C; Doherty R; Chan S; Green AR; Rakha E; Ball G; Ellis IO; Curtin NJ; Madhusudan S
    Mol Oncol; 2015 Mar; 9(3):569-85. PubMed ID: 25468710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
    Sankunny M; Parikh RA; Lewis DW; Gooding WE; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2014 Feb; 53(2):129-43. PubMed ID: 24327542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for XRCC2 gene polymorphisms in breast cancer risk and survival.
    Lin WY; Camp NJ; Cannon-Albright LA; Allen-Brady K; Balasubramanian S; Reed MW; Hopper JL; Apicella C; Giles GG; Southey MC; Milne RL; Arias-Pérez JI; Menéndez-Rodríguez P; Benítez J; Grundmann M; Dubrowinskaja N; Park-Simon TW; Dörk T; Garcia-Closas M; Figueroa J; Sherman M; Lissowska J; Easton DF; Dunning AM; Rajaraman P; Sigurdson AJ; Doody MM; Linet MS; Pharoah PD; Schmidt MK; Cox A
    J Med Genet; 2011 Jul; 48(7):477-84. PubMed ID: 21632523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas.
    Parikh RA; Appleman LJ; Bauman JE; Sankunny M; Lewis DW; Vlad A; Gollin SM
    Genes Chromosomes Cancer; 2014 Jan; 53(1):25-37. PubMed ID: 24142626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers.
    Lewis KA; Bakkum-Gamez J; Loewen R; French AJ; Thibodeau SN; Cliby WA
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1061-8. PubMed ID: 17879369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
    Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
    J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.
    Pooley KA; Baynes C; Driver KE; Tyrer J; Azzato EM; Pharoah PD; Easton DF; Ponder BA; Dunning AM
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3482-9. PubMed ID: 19064565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles.
    Chevarin M; Alcantara D; Albuisson J; Collonge-Rame MA; Populaire C; Selmani Z; Baurand A; Sawka C; Bertolone G; Callier P; Duffourd Y; Jonveaux P; Bignon YJ; Coupier I; Cornelis F; Cordier C; Mozelle-Nivoix M; Rivière JB; Kuentz P; Thauvin C; Boidot R; Ghiringhelli F; O'Driscoll M; Faivre L; Nambot S
    Oncotarget; 2023 Feb; 14():111-125. PubMed ID: 36749285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population.
    Wang S; Zhang Y; Chen M; Wang Y; Feng Y; Xu Z; Zhang D; Sun Y; Fu Z
    Oncotarget; 2018 Jun; 9(42):26616-26624. PubMed ID: 29928473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
    Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
    BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Atr-Chek1 pathway inhibits axon regeneration in response to Piezo-dependent mechanosensation.
    Li F; Lo TY; Miles L; Wang Q; Noristani HN; Li D; Niu J; Trombley S; Goldshteyn JI; Wang C; Wang S; Qiu J; Pogoda K; Mandal K; Brewster M; Rompolas P; He Y; Janmey PA; Thomas GM; Li S; Song Y
    Nat Commun; 2021 Jun; 12(1):3845. PubMed ID: 34158506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.
    Sinha S; Singh RK; Bhattacharya N; Mukherjee N; Ghosh S; Alam N; Roy A; Roychoudhury S; Panda CK
    Mol Oncol; 2011 Oct; 5(5):454-64. PubMed ID: 21803008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
    Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
    Einarsdóttir K; Rosenberg LU; Humphreys K; Bonnard C; Palmgren J; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
    Breast Cancer Res; 2006; 8(6):R67. PubMed ID: 17132159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
    Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
    Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival.
    Abraham JE; Harrington P; Driver KE; Tyrer J; Easton DF; Dunning AM; Pharoah PD
    Clin Cancer Res; 2009 Mar; 15(6):2181-91. PubMed ID: 19276290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHEK1 coordinates DNA damage signaling and meiotic progression in the male germline of mice.
    Abe H; Alavattam KG; Kato Y; Castrillon DH; Pang Q; Andreassen PR; Namekawa SH
    Hum Mol Genet; 2018 Apr; 27(7):1136-1149. PubMed ID: 29360988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tagging single nucleotide polymorphisms in phosphoinositide-3-kinase-related protein kinase genes involved in DNA damage "checkpoints" and lung cancer susceptibility.
    Hu Z; Liu H; Wang H; Miao R; Sun W; Jin G; Wang Y; Ma H; Jin L; Wei Q; Lu D; Huang W; Shen H
    Clin Cancer Res; 2008 May; 14(9):2887-91. PubMed ID: 18451257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.